CCND1 and breast cancer: Authors based on bioinformatic tools, pathway enrichment and network analyses confirmed that Cyclin D1 overexpression, known for its oncogenic roles as regulator of cell cycle [91] and breast cancer aggressiveness [129], could be a target of EGCG.